Condensed Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Revenues
Product sales	$ 439	$ 355	$ 2,344	$ 1,020
License, royalty and development fees	153	142	461	652
Total revenues	592	497	2,805	1,672
Cost of sales	242	182	869	620
Gross profit	350	315	1,936	1,052
Operating expenses
Research, development and regulatory	75	84	228	277
Selling, general and administrative	297	325	1,032	981
Total operating expenses	372	409	1,260	1,258
Income (loss) from operations	(22)	(94)	676	(206)
Interest and other expenses
Interest expense	89	91	269	287
Total interest and other expense	89	91	269	287
Net income (loss)	$ (111)	$ (185)	$ 407	$ (493)
Net income (loss) per common share, basic	$ (0.01)	$ (0.01)	$ 0.02	$ (0.02)
Net income (loss) per common share, diluted	$ (0.01)	$ (0.01)	$ 0.02	$ (0.02)
Shares used in computing net income (loss) per common share, basic	21,491	21,491	21,491	21,491
Shares used in computing net income (loss) per common share, diluted	21,491	21,491	22,631	21,491